Here is the information about what affects the price of ONC.TO stocks: Company Performance: Positive earnings reports or successful clinical trial outcomes generally boost the stock price.

Market Sentiment: Overall investor optimism or pessimism towards the biotech sector can influence demand for ONC.TO shares.

Regulatory Approvals: Approval of OncoSec's products by regulatory bodies like the FDA can significantly increase stock value.

Competition: Developments from rival companies developing similar cancer therapies can impact investor perception of OncoSec.

Economic Conditions: Broader economic factors such as interest rates and inflation can affect investment decisions in riskier assets like biotech stocks.

Financing Activities: Stock dilution from new share offerings typically puts downward pressure on the price.

Industry Trends: Advancements in cancer immunotherapy or gene therapy can create positive momentum for companies in the space, including OncoSec.

Management Changes: Significant changes in the company's leadership team can create uncertainty and affect investor confidence.

Partnerships and Acquisitions: Strategic alliances or acquisition offers can drive up the stock price due to increased potential and valuation.

Clinical Trial Data: Positive or negative data from clinical trials are very important factors in determing stock values.